Oberland Capital
Finance · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1700 Broadway Fl 37, New York City, New ...Phone Number
(212) 257-5850Website
www.oberlandcapital.comRevenue
$12 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
2
2
1
2
About Oberland Capital
Oberland Capital is a private investment firm focused on funding innovation in the global healthcare industry, managing approximately $3 billion in assets. The firm specializes in flexible investment structures tailored to meet the specific needs of its partners, offering a range of financing solutions including monetization of royalty streams and project-based financing. With a team of 25 experts, Oberland Capital aims to accelerate the development and commercialization of healthcare products, providing significant capital investments between $50 million and $300 million. Their strategic approach combines global reach, deep domain expertise, and collaborative partnerships to transform patient care.Explore more
Oberland Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Oberland Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Oberland Capital
Click to see if Oberland Capital had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Oberland Capital has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Oberland Capital has new funding data
Product Launch: Get notified when Oberland Capital launches new products
Oberland Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Oberland Capital recently announced quarterly report
Check out if Oberland Capital is spiking on competitors!
Recommended Actions
Find VP level buyers at Oberland Capital
Find 3 more new buyers
Compare Similar Companies to Oberland Capital
Compare insights from companies similar to Oberland Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oberland Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Oberland Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Oberland Capital.
Oberland Capital Tech Stack
A closer look at the technologies used by Oberland Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Oberland Capital News & Media
Biohaven Announces Investment up to $600 Million by Oberland Capital - Stock Titan
$250M immediate funding backs troriluzole development for untreated genetic disorder. Strategic deal includes milestone-based funding for FDA approval. Get details.Verastem Oncology Secures $150M Credit Facility, IQVIA Partnership for Cancer Drug Launch
Verastem strengthens financial position with $150M credit facility and strategic IQVIA partnership to support 2025 launch of avutometinib for ovarian cancer treatment.Verastem Oncology Announces Debt Refinancing with Oberland Capital and Strategic Commercialization Partnership with IQVIA to Support Potential Launch in Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer in Mid-2025
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced a new credit facility for up to $150 million along with an equity investment of $7.5 million with Oberland Capital Management LLC (Oberland Capital). In addition, the Company announced a strategic collaboration with IQVIA Inc. (IQVIA) to leverage IQVIA’s world-class infrastructure and established commercialCategory Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with Oberland Capital
Proceeds Strengthen the Balance Sheet and Secure the Path to Profitability and IPO, Ensuring Increasing Industry Leadership MENLO PARK, Calif., Sept. 4, 2024 /PRNewswire/ -- BillionToOne, a next-generation molecular diagnostics company, announced it closed a $140 million non-dilutive...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oberland Capital
Sign Up For FreeTo access detailed company insights
Oberland Capital is a private investment firm focused on funding innovation in the global healthcare industry, managing approximately $3 billion in assets. The firm specializes in flexible investment structures tailored to meet the specific needs of its partners, offering a range of financing solutions including monetization of royalty streams and... Read More
